Skip to main content

famotidine

NDC 68475-400 · Navinta LLC

Generic namefamotidine
Dosage formPOWDER, FOR SUSPENSION
RouteORAL
Active ingredient(s)FAMOTIDINE
Strength40 mg/5mL
Pharmacologic classHistamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
Marketing categoryANDA

Packages

68475-400-01 — 50 mL in 1 BOTTLE, PLASTIC (68475-400-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

68071-3420 — FAMOTIDINE, 68071-3521 — Famotidine, 68071-3584 — FAMOTIDINE, 68071-3786 — Famotidine, 68071-4197 — Famotidine, 68094-054 — FAMOTIDINE, 68180-150 — Famotidine, 68196-121 — Famotidine, 68382-444 — famotidine, 68391-300 — Famotidine, 68645-594 — Famotidine, 68788-4021 — Famotidine, 68788-4088 — Famotidine, 68788-4119 — Famotidine, 68788-4144 — Famotidine, 68788-8485 — FAMOTIDINE, 68788-8518 — FAMOTIDINE, 68788-8733 — Famotidine, 68788-8889 — Famotidine, 68788-8897 — Ibuprofen and famotidine, +401 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources